122-0551

DRUG2 trials

Sponsors

Therapeutics, Inc.

Conditions

Plaque PsoriasisPsoriasis

Phase 2

Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression

CompletedNCT01698333

Therapeutics, Inc.Plaque Psoriasis

Start: 2012-04-30End: 2013-07-31Updated: 2018-10-24

A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis

CompletedNCT01700985

Therapeutics, Inc.Plaque Psoriasis, Psoriasis

Start: 2012-05-31End: 2013-03-31Updated: 2018-10-25